RELATION OF PRODUCT FORMULATION TO ABSORPTION OF ORAL THEOPHYLLINE

[1] BELL T, 1978, PEDIATRICS, V62, P352

[2] ELLIS EF, 1976, PEDIATRICS, V58, P542

[3] Gibaldi M, 1975, PHARMACOKINETICS

[4] RELATIONSHIP OF THEOPHYLLINE CLEARANCE TO ORAL DOSAGE IN CHILDREN WITH CHRONIC ASTHMA [J]. JOURNAL OF PEDIATRICS, 1977, 91 (04) : 655 - 660

[5] HAMBLETON G, 1977, LANCET, V1, P381

[6] HENDELES L, 1978, AM J DIS CHILD, V132, P876

[7] FREQUENT TOXICITY FROM IV AMINOPHYLLINE INFUSIONS IN CRITICALLY ILL PATIENTS [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1977, 11 (01): : 12 - 18

[8] ABSOLUTE BIOAVAILABILITY OF ORAL THEOPHYLLINE [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (05): : 525 - 527

[9] HENDELES L, 1978, AM REV RESPIR DIS, V118, P97

[10] CLINICAL EXPERIENCE WITH THEOPHYLLINE - RELATIONSHIPS BETWEEN DOSAGE, SERUM CONCENTRATION, AND TOXICITY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (18): : 1983 - 1986

[1] BELL T, 1978, PEDIATRICS, V62, P352

[2] ELLIS EF, 1976, PEDIATRICS, V58, P542

[3] Gibaldi M, 1975, PHARMACOKINETICS

[4] RELATIONSHIP OF THEOPHYLLINE CLEARANCE TO ORAL DOSAGE IN CHILDREN WITH CHRONIC ASTHMA [J]. JOURNAL OF PEDIATRICS, 1977, 91 (04) : 655 - 660

[5] HAMBLETON G, 1977, LANCET, V1, P381

[6] HENDELES L, 1978, AM J DIS CHILD, V132, P876

[7] FREQUENT TOXICITY FROM IV AMINOPHYLLINE INFUSIONS IN CRITICALLY ILL PATIENTS [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1977, 11 (01): : 12 - 18

[8] ABSOLUTE BIOAVAILABILITY OF ORAL THEOPHYLLINE [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (05): : 525 - 527

[9] HENDELES L, 1978, AM REV RESPIR DIS, V118, P97

[10] CLINICAL EXPERIENCE WITH THEOPHYLLINE - RELATIONSHIPS BETWEEN DOSAGE, SERUM CONCENTRATION, AND TOXICITY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (18): : 1983 - 1986